Hyderabad, Dec 28 (Hydnow): Allaying fears among people following the surge of covid infections due to JN.1 the new sub-variant of the coronavirus, former Director General of Indian Council of Medical Research (ICMR), Dr. Balram Bhargava said that initial signs of the recent rise of covid cases clearly indicate mild infections.
Dr. Bhargava, who played a central role in the country’s response during the three waves of the Covid pandemic, said the Serum Institute was developing a vaccine that has the potential to provide protection even from the recently identified JN.1 sub-variant.
“Serum Institute has a vaccine based on nanotechnology, which has been exported to the United States. While it is still early days, this vaccine has a lot of promise and appears to be effective against the JN.1, he said. (Hydnow)
Advertisements
Next Story :
-
Indian Students In Kyrgyzstan Fear Attacks, Seek Evacuation Amid Rising Violence
Indian students, including many from the Telugu states, have expressed growing fears for their safety in Kyrgyzstan following escalating violence.
-
New COVID-19 Wave Grips Singapore
Singapore is seeing a new COVID wave as the authorities recorded more than 25,900 cases from May 5 to 11 even as Health Minister Ong Ye Kung on Saturday advised the wearing of masks again.
-
PA Of Arvind Kejriwal Arrested In Swati Maliwal Case
Delhi Police on Saturday arrested Delhi Chief Minister Arvind Kejriwal PA Bibhav Kumar in the case of assault on AAP MP Swazti Maliwal.
-
Telangana: Warning Issued Over Counterfeit Erectile Dysfunction Drug ‘Pulmosil Injection Containing Fungus’
Authorities in Telangana have cautioned the public about the availability and sale of a counterfeit version of sildenafil, a drug supposed to cure erectile dysfunction.
Now you can get the latest stories from Hydnow every day. Click the link to subscribe. Click to follow Hydnow’s Facebook page and Twitter and Instagram